Fresenius Group Overview

  • Annual Report 2016

    “Bringing continuous improvements in care to ever more people will remain our challenge, well into the future.”

New Developments

To our shareholders

“2016 was a very eventful year for Fresenius. Each of our four business segments continued to make progress. A milestone was the acquisition of the Spanish hospital operator Quirónsalud by Fresenius Helios.”

Stephan Sturm, Chairman of the Management Board

Financial Highlights


€ 29.1 bn


2015: €27.6 bn


€ 4327 m


2015: €3,958 m2

Net Income3



2015: €1,423 m2

Dividend Proposal

+ 13 %

to €0.62 per share

24th Consecutive Dividend Increase



2015: 222,305

Earnings per Share3

€ 2.92


2015: €2.61


1 In constant currency

2 Before special items

3 Net income attributable to shareholders of Fresenius SE & Co. KGaA; 2015 before special items


  • Fresenius Medical Care

    In 2016, Fresenius Medical Care achieved strong sales and earnings growth. We further strengthened our leading position in the global dialysis market – especially in the services area.

  • Fresenius Kabi

    Our business grew organically in all regions and product segments. In the emerging markets, China and Latin America showed particularly strong growth. Organic sales growth of 5% and EBIT growth of 5% in constant currency exceeded original expectations.

  • Fresenius Helios

    The acquisition of Quirónsalud is an important strategic step that significantly expands our position as the largest private hospital operator in Europe. We further improved our business in Germany, and reached our sales and earnings targets.

  • Fresenius Vamed

    Both the service and project business developed very well. Our sales and earnings targets were achieved. Order intake exceeded the € 1 billion mark for the first time. This forms an excellent basis for future growth.

24th Consecutive Dividend Increase

Fresenius shares are an attractive investment. Anyone who invested € 1,000 five years ago and reinvested the dividends would have increased their capital to € 3,179 as of December 31, 2016. That is an average annual return of 27% (before expenses and taxes).

All Financial Reports